Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data

European Journal of Human Genetics

Volumn 22, Issue 10, 2014, Pages 1239-1242

  Radmanesh, Farid ^a,b   Devan, William J ^a,b   Anderson, Christopher D ^a,b   Rosand, Jonathan ^a,b   Falcone, Guido J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

APOE; apolipoprotein E; epsilon alleles; GWAS; imputation

Indexed keywords

APOLIPOPROTEIN E;

ACCURACY; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC PROCEDURES; GENOTYPE; HUMAN; HUMAN GENOME; HYPOTHESIS; IMPUTATION; KAPPA STATISTICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CAUCASIAN; COMPARATIVE STUDY; GENETICS; GENOTYPING TECHNIQUE; HAPLOTYPE MAP; LONGITUDINAL STUDY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; PROSPECTIVE STUDY; QUALITY CONTROL; STATISTICAL MODEL;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GENOTYPING TECHNIQUES; HAPMAP PROJECT; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; QUALITY CONTROL;

EID: 84927012162     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.308     Document Type: Article

References (17)

1. Laws SM, Hone E, Gandy S, Martins RN: Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 2003; 84: 1215-1236.
2. Corder EH, Saunders AM, Strittmatter WJ et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
3. Pastor P, Roe CM, Villegas A et al: Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol 2003; 54: 163-169.
4. Saunders AM, Strittmatter WJ, Schmechel D et al: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472.
5. West HL, Rebeck GW, Hyman BT: Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994; 175: 46-48.
6. Biffi A, Sonni A, Anderson CD et al: Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010; 68: 934-943.
7. Donnelly LA, Palmer CN, Whitley AL et al: Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study. Pharmacogenet Genomics 2008; 18: 279-287.
8. Lill CM, Liu T, Schjeide BM et al: Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. J Med Genet 2012; 49: 558-562.
9. Genes for Cerebral Hemorrhage on Anticoagulation Collaborative G. Exploiting common genetic variation to make anticoagulation safer. Stroke 2009; 40: S64-S66.
10. Mueller SG, Weiner MW, Thal LJ et al: Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's disease neuroimaging initiative (ADNI). Alzheimers Dement 2005; 1: 55-66.
11. Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT: Data quality control in genetic case-control association studies. Nat Protoc 2010; 5: 1564-1573.
12. Genomes Project C, Abecasis GR, Altshuler D et al: A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-1073.
13. Howie BN, Donnelly P, Marchini J: A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529.
14. Delaneau O, Marchini J, Zagury JF: A linear complexity phasing method for thousands of genomes. Nature Methods 2012; 9: 179-181.
15. Purcell S, Neale B, Todd-Brown K et al: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
16. Verghese PB, Castellano JM, Holtzman DM: Apoliporotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011; 10: 241-252.
17. Delaneau O, Marchini J: The 1000 Genomes Project Consortium. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Under review 2013. Available at http://mathgen.stats.ox.ac.uk/impute/data-download-1000G-phase1-integrated-SHAPEIT2.html.